Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins
about
Biomedical applications of glycosylphosphatidylinositol-anchored proteinsCo-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cellsAntibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccinationCharacterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsidEnhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant.Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles.Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responsesInfluenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Developments in virus-like particle-based vaccines for HIV.Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.
P2860
Q27468625-B1831CA1-4A0A-4B19-96A3-04B9DE42121FQ28732043-4E9035AB-F878-4D93-A90D-B8F9313BC7C1Q33873719-AA5E6666-B30F-45F9-A592-B05254D476D1Q33900222-F586A7F8-4D5C-48EF-9B52-1A9A1459F2DEQ34036827-6C0E5C67-2E95-4A43-A2DD-875EF4BD01B3Q34576055-992C1142-A8B7-438E-A407-C1A63209F887Q34637968-69BCC8C8-FF79-4321-9C50-DCDCB4044BEDQ35181739-DA25DF0C-173C-4EA7-A798-AA11FF024C32Q35883016-3DA93B9C-5141-4B75-B176-51B1712E233DQ36207818-369F35AF-C5E7-4CB8-99C6-CF0E50A4A947Q37951525-6EFE723B-15D0-4CBC-853D-94DF5919733FQ38081965-20394027-C1CC-4164-9485-85802DC7400FQ47276928-A8DBA13A-DA19-4BAC-8CE5-E12008474804
P2860
Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@ast
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@en
type
label
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@ast
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@en
prefLabel
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@ast
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@en
P2093
P2860
P1433
P1476
Immunogenicity of virus-like p ...... ciency virus envelope proteins
@en
P2093
Andrei Vzorov
Chunzi Huang
Fu-Shi Quan
Gangadhara Sailaja
Richard W Compans
Sang-Moo Kang
P2860
P304
P356
10.1016/J.VACCINE.2007.01.107
P407
P577
2007-02-15T00:00:00Z